French clinical-stage biotech AlgoTherapeutics (AlgoTx) today announced the completion of its 276 patient Phase II trial, known as ACT, with ATX01 in chemotherapy-induced peripheral neuropathy (CIPN).

The foot care product market is poised for steady growth, driven by rising health awareness, aging populations, and increasing demand for personalized solutions ...

In the realm of health and wellness, nerve health often takes a backseat despite its paramount importance. Neuropathy, ...

Sonnet is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action. Known as F H AB (Fully H ...

In today’s fast-paced world, many individuals experience nerve discomfort due to various factors, including age, lifestyle, ...

Nerve Renew is a dietary supplement designed to address neurological problems and restore healthy nerve function. The formula ...

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

No ban on methylcobalamin in health supplements & nutraceutical products: Health ministry: Shardul Nautiyal, Mumbai Wednesday, February 5, 2025, 08:00 Hrs [IST] The Union health m ...

In recent weeks, reports have been circulating about severe reactions in people who've taken over-the-counter vitamin B6 ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

Vitamin B6 can cause permanent damage to nerves. Studies have shown symptoms improved when the person stopped taking the ...